プロモーションスケジュール Pulse Biosciences, Inc.
詳細なスケジュール
簡易グラフ
会社について
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.
| Цена ао |
8.25 |
| Выручка |
0.000114 |
| EBITDA |
-0.0468 |
| P/S |
4865.77 |
| P/BV |
9.52 |
| EV/EBITDA |
-6.25 |
| ISIN |
US74587B1017 |
| Сайт |
https://www.pulsebiosciences.com
|
| Число акций ао |
0.04804 млрд |
| Валюта |
usd |
| IPO date |
2016-05-18 |
| Sector |
Health Care |
| Industry |
Health Care Equipment & Supplies |
| Валюта отчета |
usd |
| 1日あたりの価格変動: |
+3.79% (16.1) |
| 週ごとの価格変動: |
-2.88% (17.205) |
| 月ごとの料金変更: |
-4.41% (17.48) |
| 3ヶ月間の価格変動: |
+7.74% (15.51) |
| 半年間の価格変動: |
+121.91% (7.53) |
| 年間の価格変動: |
+285.91% (4.33) |
| 3年間の価格推移: |
-24.08% (22.01) |
| 5年間の価格推移: |
+41.37% (11.82) |
| 年初からの価格変動: |
+208.87% (5.41) |
|
|
過小評価
| 名前 |
意味 |
学年 |
| P/S |
-67573.45 |
0 |
| P/BV |
13.71 |
1 |
| P/E |
0 |
0 |
| EV/EBITDA |
-13.52 |
0 |
| 合計: |
|
1.88 |
|
効率
| 名前 |
意味 |
学年 |
| ROA, % |
-69.42 |
0 |
| ROE, % |
-95.15 |
0 |
| 合計: |
|
3.33 |
|
|
|
配当金
| 名前 |
意味 |
学年 |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| 合計: |
|
0 |
|
義務
| 名前 |
意味 |
学年 |
| Debt/EBITDA |
-0.2158 |
10 |
| 合計: |
|
9.8 |
|
成長の衝動
| 名前 |
意味 |
学年 |
| 収益性 Revenue, % |
-103.64 |
0 |
| 収益性 Ebitda, % |
-9.47 |
0 |
| 収益性 EPS, % |
-60.42 |
0 |
| 合計: |
|
0 |
|
| スーパーバイザー |
役職 |
支払い |
生年 |
| Mr. Robert W. Duggan |
Executive Co-Chairman |
N/A |
1944 (80 年) |
| Mr. Darrin R. Uecker |
CTO & Director |
834.73k |
1966 (58 年) |
| Mr. Mitchell E. Levinson |
Chief Strategy Officer |
584.57k |
1960 (64 年) |
| Dr. Richard Nuccitelli Ph.D. |
Chief Science Officer |
N/A |
|
| Mr. Kenneth B. Stratton Esq., J.D. |
General Counsel & Corporate Secretary |
N/A |
1969 (55 年) |
| Ms. Patty Perla |
Vice President of Human Resources |
N/A |
|
| Mr. David Danitz |
Senior Vice President of Engineering |
N/A |
|
| Mr. Kevin P. Danahy |
Chief Commercial Officer |
|
1971 (53 年) |
| Mr. Burke T. Barrett |
President, CEO & Director |
|
1964 (60 年) |
| Mr. Edison Manuel |
Vice President of Operations |
|
|
